comparemela.com
Home
Live Updates
AbbVie to acquire ADC manufacturer ImmunoGen for $10.1B in oncology play : comparemela.com
AbbVie to acquire ADC manufacturer ImmunoGen for $10.1B in oncology play
The ImmunoGen deal, which is expected to close in the middle of 2024, is also estimated to be accretive to AbbVie’s diluted earnings per share beginning in 2027.
Related Keywords
Shanghai ,
China ,
Richarda Gonzalez ,
Eli Lilly ,
Mablink Bioscience ,
Kristen Harrington Smith ,
Mark Enyedy ,
Drug Administration ,
Bristol Myers Squibb ,
Johnson ,
Biologic License Application ,
Marketing Authorization Application ,
Big Pharma ,
Munich Based Tubulius ,
Bliss Biopharmaceutical ,
comparemela.com © 2020. All Rights Reserved.